Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
great news!!!! GO VTEQ.
I believe that this information is true .......
Anyone know if it is true?
I found this information on yahoo finance forum is true?
Sue is correct the fda gave NVLX the go ahead here its right here for all to read.
In one study led by researchers at St George's, University of London, and published in Anticancer Research in late 2013, scientists studying six different cannabinoids found that each possessed anti-cancer properties similar to those observed with THC, and further, that the positive effect of cannabinoids on in leukemia cancer cells increased when they were combined with other cannabis-derived compounds.
In November 2013 the FDA gave Nuvilex Inc. and its subsidiary MM Sciences, sponsors of the University of London study, permission to begin clinical trials of CBD. The approval appears to signify a shift in the level of support given to cannabis research by federal regulators.
According to the FDA, among the 60-some known cannabinoids found in cannabis, CBD is the second most abundant (after THC) and offers therapeutic benefits without the "high" which can be psychologically disturbing for some individuals or lead to addictions in others.
As more states approve the use of #$%$” for pain management and regulators express interest in the potential therapeutic benefit of cannabis in disease management, it's likely that cannabis research will also grow exponentially, and lead to a greater number of cannabis-based medicines reaching the marketplace over the next decade.
I disagree, with the article seekhing alpha. The author of this article says there is no investment in R+D in the last report submitted. ¡¡¡¡¡¡ no, of course not !!!!!!!!!!; only a few days ago Nuvilex achievement financing operations agreement with Lincoln Park. From now on there is already money for R & D for phase 3.
The author of this article says nothing new, I imagine that was paid by a bear.
I think this will be great company, great.
Bull.
Comment very successful, I believe in this company.
Thanks for your answer.
Anyone know any news that the price impact of declining vteq?.
TOTALLY agree; there are people who want to do harm. If we look the article sekhing alpha anonymous author, says nothing new. I think there is a high probability for success of this company. This supported by the recent investment of $ 27 million and its technology, with recognized experts in the field. it Is normal for a company in its infancy haven't earnings, have to spend some time to reach equilibrium. But the important thing here is knowledge.
Agreed!, I think we may be coming next week for $ 52 resistance.
what do you think?
This company will be great in the short time according to your different market area.
I agree. has much potential this company.
Another reason to believe in this company. They are starting their
operations. recognized scientists.
News!!!!
http://finance.yahoo.com/news/nuvilex-accelerates-development-treatments-cancer-151500970.html
Thanks for the reply, I hope you get to $ 17
I do not understand, if Ford's results were very positive ....
Why? what happens? the action does not behave as it should be higher.
Can anyone explain me......
But,tomorrow will be terminates the correction and the upward trend again, for the presentation of results.?.
Definitely, i think more every day in this company, innovative ideas will be a revolution in the treatment of cancer. Monday can be a milestone in this company. Many pharmaceutical are attentive.
Can you explain what your basis for believing in HIPP?, I am researching on this asset and from what I have read, has been affected by a regulation, but I think there is potential!.
I would appreciate the answer.
I think this is not a bomb, it is simply the recognition of this company by its projection.
And expect more that will continue to grow.
Tranquility, at some point has to improve. This company has very good prospects and the decisions the board are laying the foundation for exponential growth. This company has a very good projection. This sector of biotechnology.
Totally agree. This company will be winner and will grow, has on his side the FDA and in Europe are expanding their business. Good short-term projections..